Initial alpha-1 antitrypsin screening in Turkish patients with chronic obstructive pulmonary disease
Turkish Journal of Medical Sciences · 18.08.2023 · 53 (4) · 1012-1018
DOI: 10.55730/1300-0144.5665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 18.08.2023. Verfasst von Seda Tural Önür. Beteiligte Einrichtung: Department of Pulmonology, Yedikule Chest Diseases and Thoracic Surgery Education and Research Hospital, University of Health Sciences, İstanbul, Tur…. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin Deficiency, Bronchiectasis, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: COPD
Abstract (Originalsprache)
Background/aim: Alpha-1 antitrypsin (AAT) deficiency is associated with several types of pathology, and the reported effects of mutations in the ATT-encoding gene vary worldwide. No Turkish study has yet appeared. We thus explored the AAT status of Turkish patients with chronic obstructive pulmonary disease (COPD). Materials and methods: This prospective cross-sectional study included outpatients and inpatients treated from June 2021 to June 2022. Serum AAT levels were checked, and dry blood samples were subjected to genetic analysis.
Results
Genetic mutations were found in 21 (3.52%) of 596 patients with prior and new COPD diagnoses treated in our pneumonology outpatient department. The mean serum AAT level was 114.80 mg/dL (minimum 19, maximum 209; standard deviation 27.86 mg/dL). The most frequent mutation was M/Plowell (23.8%, n = 5), followed by M/S (23.8%, n = 5), M/I (19%, n = 4), M/Malton (14.3%, n = 3), Z/Z (9.5%, n = 2), M/Z (4.8%, n = 1), and Kayseri/Kayseri (4.8%, n = 1). Thoracic computed tomography revealed that 85.7% (n = 18) of all patients had emphysema, 28.5% (n = 6) had bronchiectasis, and 28.5% (n = 6) had mass lesions. Of the emphysema patients, 55% (n = 10) had only upper lobe emphysema, and 83.3% (n = 15) had emphysema in additional areas, but statistical significance was lacking (p > 0.05).
Conclusion
In patients with emphysema and normal serum AAT levels, genetic analyses may reveal relevant heterozygous mutations, which are commonly ignored. Most clinicians focus on lower lobe emphysema. Evaluations of such patients might reveal AAT mutations that are presently overlooked because they are not considered to influence COPD status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonology, Yedikule Chest Diseases and Thoracic Surgery Education and Research Hospital, University of Health Sciences, İstanbul, Turkiye.
Zitieren
APA
Önür, S. T. (2023). Initial alpha-1 antitrypsin screening in Turkish patients with chronic obstructive pulmonary disease. Turkish Journal of Medical Sciences, 53(4), 1012-1018. https://doi.org/10.55730/1300-0144.5665
Vancouver
Önür ST. Initial alpha-1 antitrypsin screening in Turkish patients with chronic obstructive pulmonary disease. Turkish Journal of Medical Sciences. 2023;53(4):1012-1018. doi:10.55730/1300-0144.5665
BibTeX
@article{nr2023,
author = {Önür, Seda Tural},
title = {Initial alpha-1 antitrypsin screening in Turkish patients with chronic obstructive pulmonary disease},
journal = {Turkish Journal of Medical Sciences},
year = {2023},
volume = {53},
number = {4},
pages = {1012--1018},
doi = {10.55730/1300-0144.5665}
}
EUVIMED